The global coronary stents market was valued at US$ 7,222.5 Mn in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2035, crossing US$ 12,846.6 Mn by the end of 2035. Market growth is being fueled by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and continuous advancements in drug-eluting stent (DES) technologies.
Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23
Market Overview
Coronary stents are small, tube-like medical devices inserted into narrowed or blocked coronary arteries to restore normal blood flow to the heart. These devices are primarily used in patients suffering from coronary artery disease (CAD), a condition characterized by plaque buildup that restricts oxygen-rich blood supply to the heart muscle.
Coronary stents are typically deployed during angioplasty procedures, where a balloon catheter widens the blocked artery before the stent is placed to maintain vessel patency. There are two primary types of coronary stents: drug-eluting stents (DES) and bare-metal stents (BMS). While BMS mechanically keep arteries open, they are associated with a higher risk of restenosis due to scar tissue formation. DES were developed to overcome this limitation by gradually releasing medication to prevent artery re-narrowing and reduce clot formation risks.
Key Market Growth Drivers
Increasing Demand for Minimally Invasive Procedures
The growing preference for minimally invasive cardiovascular interventions is a significant driver of the coronary stents market. Procedures such as percutaneous coronary intervention (PCI) offer several advantages over traditional open-heart surgeries, including shorter hospital stays, reduced post-procedure discomfort, and lower complication rates.
Patients are increasingly opting for treatment options that allow quicker recovery and improved quality of life. Coronary stenting has become a widely accepted and reliable treatment for CAD, offering minimal physical trauma and high procedural success rates.
Favorable Reimbursement Policies
Supportive reimbursement frameworks across major healthcare markets are playing a pivotal role in driving coronary stent adoption. Many countries have implemented reimbursement policies that cover coronary stenting procedures, minimizing out-of-pocket expenses for patients and improving access to advanced cardiovascular treatments.
Governments and insurance providers are increasingly willing to reimburse next-generation stents, including drug-eluting and bioresorbable stents, due to their demonstrated clinical benefits and reduced long-term complication rates. Additionally, the shift toward value-based healthcare reimbursement models—where patient outcomes and cost-efficiency are prioritized—encourages continuous innovation in stent technologies.
Analysis of Key Players
The coronary stents market is highly competitive, with key players focusing on product innovation, regulatory approvals, and geographic expansion to strengthen their market positions. Companies are actively seeking approvals from regulatory bodies such as the FDA and EMA to ensure compliance with stringent safety and efficacy standards.
Prominent players operating in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, B. Braun Melsungen AG, Cook Medical Inc., Elixir Medical Corp., and Lepu Medical Technology (Beijing) Co., Ltd., among others.
Market Challenges & Opportunities
Despite positive growth prospects, the coronary stents market faces challenges including stringent regulatory approval processes, high product development costs, and concerns related to long-term safety of certain bioresorbable stents.
However, significant opportunities exist in emerging markets where cardiovascular disease prevalence is rising rapidly and healthcare infrastructure is expanding. Ongoing research and development efforts aimed at improving stent performance, reducing thrombosis risk, and enhancing bioresorption capabilities are expected to unlock new growth avenues.
Explore our report to uncover in-depth insights – https://www.transparencymarketresearch.com/coronary-stents-market.html
Market Segmentation
By Type:
- Drug-Eluting Stents (DES)
- Bare-Metal Stents (BMS)
Drug-eluting stents dominate the market due to their ability to release medication that prevents restenosis and reduces re-intervention rates. Their superior clinical performance has established DES as the gold standard in coronary interventions.
By Material:
- Cobalt-Chromium
- Stainless Steel
- Others
High-strength metal materials such as cobalt-chromium and stainless steel provide enhanced durability, flexibility, and biocompatibility, supporting their widespread adoption.
Regional Outlook
Leading Region: North America
North America is expected to dominate the global coronary stents market due to its advanced healthcare infrastructure, strong R&D ecosystem, and substantial investments in medical technologies. The region has a well-established network of hospitals and cardiac centers equipped to perform complex interventional procedures.
The high prevalence of cardiovascular diseases driven by aging populations, sedentary lifestyles, and obesity further strengthens regional demand. Increasing adoption of drug-eluting stents among clinicians due to their proven efficacy in reducing restenosis also contributes to North America’s leadership position.
Other significant markets include Europe and Asia Pacific, where improving healthcare access and rising awareness about minimally invasive cardiac treatments are contributing to market growth.
Key Developments
- In October 2024, Elixir Medical Corp. reported significant benefits of the DynamX Coronary Bioadaptor System compared to the Resolute Onyx zotarolimus drug-eluting stent for target lesion failure (TLF) in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
- In May 2024, Abbott Laboratories launched the XIENCE Sierra Everolimus drug-eluting coronary stent system in India, offering CE-marked and unparalleled safety for interventional cardiologists treating complex cases. The stent improves on previous versions with enhanced design, new delivery system, and unique sizes.
Why Buy This Report?
- Comprehensive analysis of market size and growth forecasts through 2035
- Detailed insights into drivers, challenges, and emerging opportunities
- In-depth competitive landscape profiling leading industry players
- Regional and segment-wise performance assessment
- Strategic intelligence for investors, manufacturers, and healthcare stakeholders
Buy this Premium Research Report for exclusive, in-depth insights – https://www.transparencymarketresearch.com/checkout.php?rep_id=23<ype=S
FAQs
- What is the current size of the coronary stents market?
The market was valued at US$ 7,222.5 Mn in 2024. - What is the projected growth rate of the market?
The market is expected to grow at a CAGR of 5.3% from 2025 to 2035. - Which type of stent dominates the market?
Drug-eluting stents (DES) dominate due to their ability to prevent restenosis and improve long-term outcomes. - Which region leads the coronary stents market?
North America leads due to strong healthcare infrastructure and high cardiovascular disease prevalence. - What factors are driving market growth?
Rising demand for minimally invasive procedures, favorable reimbursement policies, and technological advancements in stent design are key growth drivers.
More Trending Reports by Transparency Market Research –
Microscopy Devices Market: https://www.transparencymarketresearch.com/microscopy-market.html
Autoinjectors Market: https://www.transparencymarketresearch.com/autoinjectors-market.html
Dental 3D Printing Market: https://www.transparencymarketresearch.com/dental-3d-printer-market.html
Computed Tomography (CT) Market: https://www.transparencymarketresearch.com/computed-tomography-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Leave a Reply